3-[(4-Phenyl-piperazin-1-yl)meth-yl]-5-(thio-phen-2-yl)-2,3-di-hydro-1,3,4-oxa-diazole-2-thione
- PMID: 23723844
- PMCID: PMC3647878
- DOI: 10.1107/S1600536813009252
3-[(4-Phenyl-piperazin-1-yl)meth-yl]-5-(thio-phen-2-yl)-2,3-di-hydro-1,3,4-oxa-diazole-2-thione
Abstract
In the title compound, C17H18N4OS2, the 2-thienyl ring is disordered over two co-planar, opposite orientations in a 0.684 (2): 0.316 ratio. The 1,3,4-oxa-diazole ring is almost co-planar with the attached 2-thienyl ring [dihedral angles of 5.34 (19) and 4.8 (5)° for the major and minor components, respectively]. The relative disposition of the thione- and ring-S atoms is anti for the major orientation of the 2-thienyl residue. Overall, the shape of the mol-ecule approximates the letter V. In the crystal, a three-dimensional architecture is consolidated by a combination of weak C-H⋯S and C-H⋯π contacts.
Figures
References
-
- Agilent (2011). CrysAlis PRO Agilent Technologies, Yarnton, England.
-
- Brandenburg, K. (2006). DIAMOND Crystal Impact GbR, Bonn, Germany.
-
- Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases